JP2012509672A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012509672A5 JP2012509672A5 JP2011537703A JP2011537703A JP2012509672A5 JP 2012509672 A5 JP2012509672 A5 JP 2012509672A5 JP 2011537703 A JP2011537703 A JP 2011537703A JP 2011537703 A JP2011537703 A JP 2011537703A JP 2012509672 A5 JP2012509672 A5 JP 2012509672A5
- Authority
- JP
- Japan
- Prior art keywords
- bacteriophage
- composition
- filamentous bacteriophage
- parkinson
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11744608P | 2008-11-24 | 2008-11-24 | |
| US61/117,446 | 2008-11-24 | ||
| PCT/US2009/065659 WO2010060073A2 (en) | 2008-11-24 | 2009-11-24 | Method for treating parkinson's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012509672A JP2012509672A (ja) | 2012-04-26 |
| JP2012509672A5 true JP2012509672A5 (enExample) | 2013-01-24 |
Family
ID=41572327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011537703A Pending JP2012509672A (ja) | 2008-11-24 | 2009-11-24 | 繊維状バクテリオファージを使用してパーキンソン病を処置するための方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20110286970A1 (enExample) |
| EP (2) | EP2478911A1 (enExample) |
| JP (1) | JP2012509672A (enExample) |
| KR (1) | KR20110091778A (enExample) |
| CN (1) | CN102223887B (enExample) |
| AU (1) | AU2009316326A1 (enExample) |
| BR (1) | BRPI0921557A2 (enExample) |
| CA (1) | CA2744339A1 (enExample) |
| CO (1) | CO6390112A2 (enExample) |
| IL (1) | IL213120A0 (enExample) |
| MX (1) | MX2011005430A (enExample) |
| NZ (1) | NZ592928A (enExample) |
| RU (1) | RU2011125971A (enExample) |
| SG (1) | SG171791A1 (enExample) |
| WO (1) | WO2010060073A2 (enExample) |
| ZA (1) | ZA201104701B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2102239T3 (da) * | 2006-11-30 | 2012-05-29 | Res Dev Foundation | Forbedrede immunoglobulin-biblioteker |
| US20110182948A1 (en) * | 2008-05-22 | 2011-07-28 | Beka Solomon | Method for treating disease characterized by plaque |
| BR112013023040A2 (pt) | 2011-03-11 | 2018-10-23 | Univ Ramot | bacteriófago filamentoso, composição farmacêutica, e, métodos para reduzir a formação de fibrilas de proteína tau ou para desagregar fibrilas pré-formadas de proteína tau em um paciente, e para tratar uma tauopatia degenerativa. |
| EP2736522A1 (en) | 2011-07-27 | 2014-06-04 | Neurophage Pharmaceuticals, Inc. | Process for the production of filamentous bacteriophage |
| US9493515B2 (en) | 2011-11-29 | 2016-11-15 | Proclara Biosciences, Inc. | Bacteriophage gene 3 protein compositions and use as amyloid binding agents |
| EA033666B1 (ru) | 2012-10-02 | 2019-11-14 | Proclara Biosciences Inc | Амилоидсвязывающие белки и их применение |
| JP2016526044A (ja) | 2013-05-28 | 2016-09-01 | ニューロファージ ファーマシューティカルズ， インコーポレイテッド | 低減された免疫原性を有する修飾されたバクテリオファージｇ３ｐアミノ酸配列を含むポリペプチド |
| KR20170085132A (ko) | 2014-12-03 | 2017-07-21 | 프로클라라 바이오사이언시즈, 인크. | 글리코실화 신호가 결핍된 변형된 박테리오파지 ｇ3ｐ 아미노산 서열을 포함하는 폴리펩티드 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003509020A (ja) * | 1999-09-03 | 2003-03-11 | ラモット・ユニバーシティ・オーソリティ・フォー・アプライド・リサーチ・アンド・インダストリアル・ディベロップメント・リミテッド | プラーク形成疾患の診断、治療、予防に有用な薬剤、組成物、その使用法 |
| WO2002042321A2 (en) * | 2000-11-24 | 2002-05-30 | Isis Innovation Limited | Mixed fibrils |
| IL163812A0 (en) * | 2002-03-05 | 2005-12-18 | Univ Ramot | Immunizing composition and method for inducing an immune response against the -secretase cleavage site of amyloid precursor protein |
| GB0305918D0 (en) * | 2003-03-14 | 2003-04-23 | Glaxo Group Ltd | Novel compounds |
| FR2855178B1 (fr) * | 2003-05-20 | 2005-08-05 | Centre Nat Rech Scient | Peptides modulateurs de l'activite du facteur de transcription engrailed |
| CA2593846A1 (en) * | 2005-01-14 | 2006-08-10 | The Regents Of The University Of California | Compositions and methods for inhibiting drusen formation and for diagnosing or treating drusen-related disorders |
| JP5096169B2 (ja) * | 2005-02-01 | 2012-12-12 | ラモット・アット・テルアビブ・ユニバーシティ | アミロイド沈着に付随する炎症および活性化されたマイクログリアにかかわる脳の炎症の処置法 |
| MX2008010612A (es) * | 2006-02-15 | 2009-03-20 | Ramot At Tel Aviv University | Bacteriofago filamentoso que exhibe proteina a como aglutinante de anticuerpos e inmunocomplejos para el suministro hacia el cerebro. |
| US20090324554A1 (en) * | 2006-07-21 | 2009-12-31 | Ramot At Tel Aviv University Ltd. | Method for inhibiting or treating a disease associated with intracellular formation of protein fibrillar or aggregates |
| US20110182948A1 (en) * | 2008-05-22 | 2011-07-28 | Beka Solomon | Method for treating disease characterized by plaque |
-
2009
- 2009-11-24 AU AU2009316326A patent/AU2009316326A1/en not_active Abandoned
- 2009-11-24 EP EP12151176A patent/EP2478911A1/en not_active Withdrawn
- 2009-11-24 SG SG2011037066A patent/SG171791A1/en unknown
- 2009-11-24 NZ NZ592928A patent/NZ592928A/xx not_active IP Right Cessation
- 2009-11-24 WO PCT/US2009/065659 patent/WO2010060073A2/en not_active Ceased
- 2009-11-24 JP JP2011537703A patent/JP2012509672A/ja active Pending
- 2009-11-24 KR KR1020117014511A patent/KR20110091778A/ko not_active Withdrawn
- 2009-11-24 BR BRPI0921557A patent/BRPI0921557A2/pt not_active IP Right Cessation
- 2009-11-24 CA CA2744339A patent/CA2744339A1/en active Pending
- 2009-11-24 EP EP09775018A patent/EP2358377A2/en not_active Withdrawn
- 2009-11-24 US US13/130,894 patent/US20110286970A1/en not_active Abandoned
- 2009-11-24 MX MX2011005430A patent/MX2011005430A/es not_active Application Discontinuation
- 2009-11-24 RU RU2011125971/15A patent/RU2011125971A/ru not_active Application Discontinuation
- 2009-11-24 CN CN2009801467441A patent/CN102223887B/zh not_active Expired - Fee Related
-
2011
- 2011-05-24 IL IL213120A patent/IL213120A0/en unknown
- 2011-06-23 CO CO11078816A patent/CO6390112A2/es not_active Application Discontinuation
- 2011-06-24 ZA ZA2011/04701A patent/ZA201104701B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mittal et al. | Cell communication by tunneling nanotubes: Implications in disease and therapeutic applications | |
| Freer et al. | The virome and its major component, anellovirus, a convoluted system molding human immune defenses and possibly affecting the development of asthma and respiratory diseases in childhood | |
| Chambers et al. | A phase 1b study of placenta‐derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis | |
| Stier et al. | Respiratory syncytial virus infection activates IL-13–producing group 2 innate lymphoid cells through thymic stromal lymphopoietin | |
| Górski et al. | Phage therapy: combating infections with potential for evolving from merely a treatment for complications to targeting diseases | |
| Fujiki et al. | Phage therapy: targeting intestinal bacterial microbiota for the treatment of liver diseases | |
| Au et al. | Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma | |
| JP2017048208A5 (enExample) | ||
| Al Ustwani et al. | Genetics on a WHIM | |
| HRP20200936T1 (hr) | Antitijela za beta amiloid | |
| EA201000785A1 (ru) | Композиции для доставки в легкие | |
| JP2016518387A5 (enExample) | ||
| PH12016500859A1 (en) | Anti-human respiratory syncytial virus (rsv) antibodies and methods of use | |
| NZ602166A (en) | Antibodies to il-6 and use thereof | |
| JP2013533269A5 (enExample) | ||
| Singh et al. | Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era | |
| JP2016513115A5 (enExample) | ||
| EA201171284A1 (ru) | Новая технология изготовления напроксена | |
| Cacciottolo et al. | Nanograms of SARS-CoV-2 spike protein delivered by exosomes induce potent neutralization of both delta and omicron variants | |
| EA201590019A1 (ru) | Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы | |
| JP2012522788A5 (enExample) | ||
| TN2012000431A1 (en) | Composition comprising the amyloid beta 1-6 peptide coupled to a virus-like particle and an adjuvant | |
| RU2011125971A (ru) | Способ лечения болезни паркинсона | |
| Toan et al. | Combination of vaccine strain measles virus and nimotuzumab in the treatment of laryngeal cancer | |
| CN102220288B (zh) | 一种肠道病毒ev71型鼠适应株573及其应用 |